Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYTP01 in Immune-Mediated Diseases
NCT07901764Not yet recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial of MYTP01 in IgA nephropathy (IgAN) and kidney transplantation (4 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Estimated Glomerular Filtration Rate at Week 12, 24-Hour Urinary Protein Excretion at Week 12 and 1 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
MYTP01
03
Conditions
IgA nephropathy (IgAN)kidney transplantation
Beyond the preview
Go deeper on NCT07901764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901764.